Cost-effectiveness of FDG-PET
Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.
Oncologic Patients
To provide detailed information about cost and effectiveness of FDG-PET in multiple oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.